Haemopoietic growth factors in paediatric oncology: a review of the literature

Paediatric Drugs
L M Wagner, W L Furman

Abstract

Recombinant haemopoietic growth factors (HGFs) are an attractive adjunct to reduce morbidity from chemotherapy regimens and their use has become widespread in paediatric oncology. Although patients receiving HGFs often have faster haematological recovery after intensive chemotherapy, this does not always translate into meaningful clinical benefits. This article reviews the clinical effectiveness of HGFs in a variety of different contexts. Most published studies have used granulocyte colony-stimulating factor (G-CSF) or granulocyte-macrophage colony-stimulating factor (GM-CSF) as prophylaxis to ameliorate the subsequent neutropenia following intensive chemotherapy. These 2 agents have also been used to mobilise peripheral blood stem cells for autologous transplantation. HGFs specific for anaemia and thrombocytopenia are currently in paediatric clinical trials and it is hoped that the proper context and administration strategy can be found to make their use clinically effective. This article also reviews data on toxicity, specifically focusing on differences between various formulations of growth factors. HGFs are expensive, and cost-benefit analyses reviewed in this article give an important perspective on the financial aspects ...Continue Reading

References

Mar 1, 1979·The Journal of Pediatrics·R B Rosen, S J Kang
Jan 2, 1992·International Journal of Cancer. Journal International Du Cancer·B I LordT M Dexter
Jun 1, 1991·Blood Reviews·S J Rosenfeld, N S Young
Jul 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·B M CurtisD Friend
Jun 1, 1991·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·W L FurmanV M Santana
Jun 1, 1991·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·N V Cheung, G Heller
Jun 14, 1990·The New England Journal of Medicine·C B MillerJ L Spivak
Dec 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·B I LordT M Dexter
Nov 25, 1995·Lancet·B V Court, K K Cheng
Sep 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R A StahelE Platzer
Jun 1, 1995·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·T R KlumppJ S Macdonald
Jun 1, 1995·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J BeyerW Stieger
Jun 7, 1995·Journal of the National Cancer Institute·J I MayordomoI García-Ribas
Jul 1, 1995·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·B ChevallierC Fizames
Mar 1, 1995·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M BoogaertsH Link
Aug 1, 1995·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·E P PaganiniD A Goodkin
Jan 1, 1993·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·V Trillet-LenoirD Tomita
May 1, 1995·Journal of Pediatric Hematology/oncology·T G AbrahamsenT F DeLaney
Jul 1, 1995·Medical and Pediatric Oncology·M N Beck, D Beck
Nov 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Sep 8, 1994·The New England Journal of Medicine·N M HeddleJ G Kelton

❮ Previous
Next ❯

Citations

Oct 23, 2003·Clinical Oncology : a Journal of the Royal College of Radiologists·J E BrownR E Coleman
May 15, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Lars M WagnerVictor M Santana
Jun 23, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ruth LadensteinAndrew Pearson

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.